Prothena Corporation plc provided earnings guidance for the year 2024. The company expects full year 2024 net cash used in operating and investing activities to be between $208 million and $225 million. The estimated full year 2024 net cash used in operating and investing activities is primarily driven by an estimated net loss of $229 million to $255 million, which includes an estimated $51 million of noncash share-based compensation expense.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
20.61 USD | -0.48% | -12.77% | -43.49% |
May. 09 | RBC Cuts Price Target on Prothena to $28 From $35, Keeps Sector Perform, Speculative Risk | MT |
May. 08 | Earnings Flash (PRTA) PROTHENA CORPORATION Posts Q1 Revenue $50,000 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-43.49% | 1.11B | |
+4.78% | 111B | |
+12.23% | 105B | |
-12.71% | 22.34B | |
-3.70% | 21.93B | |
-6.03% | 18.59B | |
-35.21% | 18.12B | |
-10.73% | 16.96B | |
+4.42% | 13.7B | |
+36.74% | 12.45B |
- Stock Market
- Equities
- PRTA Stock
- News Prothena Corporation plc
- Prothena Corporation plc Provides Earnings Guidance for the Year 2024